NO20014475D0 - Fremgangsmåte for behandling av sövn-apnoea - Google Patents

Fremgangsmåte for behandling av sövn-apnoea

Info

Publication number
NO20014475D0
NO20014475D0 NO20014475A NO20014475A NO20014475D0 NO 20014475 D0 NO20014475 D0 NO 20014475D0 NO 20014475 A NO20014475 A NO 20014475A NO 20014475 A NO20014475 A NO 20014475A NO 20014475 D0 NO20014475 D0 NO 20014475D0
Authority
NO
Norway
Prior art keywords
sleep apnea
treating sleep
snoring
racemates
monohydrate
Prior art date
Application number
NO20014475A
Other languages
English (en)
Other versions
NO20014475L (no
Inventor
Sharon Crawford Cheetham
David John Heal
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Anton Safer
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20014475D0 publication Critical patent/NO20014475D0/no
Publication of NO20014475L publication Critical patent/NO20014475L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Harvester Elements (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20014475A 1999-03-19 2001-09-14 Fremgangsmåte for behandling av sövn-apnoea NO20014475L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12518599P 1999-03-19 1999-03-19
PCT/US2000/007177 WO2000056314A1 (en) 1999-03-19 2000-03-17 Method of treating sleep apnoea

Publications (2)

Publication Number Publication Date
NO20014475D0 true NO20014475D0 (no) 2001-09-14
NO20014475L NO20014475L (no) 2001-11-14

Family

ID=22418567

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014475A NO20014475L (no) 1999-03-19 2001-09-14 Fremgangsmåte for behandling av sövn-apnoea

Country Status (26)

Country Link
US (1) US6365631B1 (no)
EP (1) EP1169029B1 (no)
JP (1) JP2003521469A (no)
KR (1) KR100682291B1 (no)
CN (1) CN1161114C (no)
AT (1) ATE294573T1 (no)
AU (1) AU773489B2 (no)
BG (1) BG106001A (no)
BR (1) BR0009080A (no)
CA (1) CA2367022A1 (no)
CZ (1) CZ298293B6 (no)
DE (1) DE60019914T2 (no)
DK (1) DK1169029T3 (no)
ES (1) ES2244420T3 (no)
HK (1) HK1044462B (no)
HU (1) HUP0200501A3 (no)
IL (2) IL145244A (no)
MX (1) MXPA01009464A (no)
NO (1) NO20014475L (no)
NZ (1) NZ514014A (no)
PL (1) PL359467A1 (no)
PT (1) PT1169029E (no)
SI (1) SI1169029T1 (no)
SK (1) SK285308B6 (no)
WO (1) WO2000056314A1 (no)
ZA (1) ZA200107678B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
BR0315084A (pt) * 2002-10-05 2005-08-16 Hanmi Pharm Ind Co Ltd Composição farmacêutica compreendendo hemiidrato cristalino de metanossulfonato de sibutramina
US20050131074A1 (en) * 2003-08-04 2005-06-16 Beckman Kristen M. Methods for treating metabolic syndrome
WO2005072715A1 (en) * 2004-01-29 2005-08-11 Sepracor Inc. Use of (s)-didesmethylsibutraminefor treating, preventing and managing a sleep disorder
US20050267176A1 (en) * 2004-02-18 2005-12-01 Sepracor Inc. Dopamine-agonist combination therapy for improving sleep quality
KR100627687B1 (ko) * 2005-04-20 2006-09-25 주식회사 씨티씨바이오 시부트라민 유리염기 함유 조성물 및 이의 제조방법
BRPI0716002A2 (pt) * 2006-11-22 2013-07-30 Sk Chemicals Co Ltd complexo de inclusço, processo de preparaÇço de um complexo de inclusço e composiÇço de tratamento e prevenÇço de hipocondria e obesidade

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
US5356934A (en) * 1990-03-29 1994-10-18 Eli Lilly And Company Selected serotonin subtype receptor agonist to treat sleep apnea
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment

Also Published As

Publication number Publication date
IL145244A0 (en) 2002-06-30
CN1161114C (zh) 2004-08-11
ATE294573T1 (de) 2005-05-15
SK285308B6 (sk) 2006-10-05
HK1044462B (zh) 2006-03-03
HUP0200501A2 (en) 2002-08-28
HUP0200501A3 (en) 2004-03-29
IL177626A0 (en) 2006-12-31
JP2003521469A (ja) 2003-07-15
EP1169029A1 (en) 2002-01-09
PL359467A1 (en) 2004-08-23
PT1169029E (pt) 2005-08-31
SK13382001A3 (sk) 2002-04-04
NO20014475L (no) 2001-11-14
AU3896800A (en) 2000-10-09
EP1169029A4 (en) 2004-01-21
DE60019914D1 (de) 2005-06-09
ZA200107678B (en) 2003-06-18
CZ298293B6 (cs) 2007-08-15
AU773489B2 (en) 2004-05-27
DE60019914T2 (de) 2006-05-04
IL145244A (en) 2006-12-10
NZ514014A (en) 2004-02-27
KR100682291B1 (ko) 2007-02-15
BR0009080A (pt) 2002-02-13
MXPA01009464A (es) 2004-03-19
ES2244420T3 (es) 2005-12-16
DK1169029T3 (da) 2005-08-29
EP1169029B1 (en) 2005-05-04
BG106001A (en) 2002-06-28
HK1044462A1 (en) 2002-10-25
CZ20013280A3 (cs) 2002-07-17
WO2000056314A1 (en) 2000-09-28
SI1169029T1 (sl) 2005-12-31
KR20010113847A (ko) 2001-12-28
CA2367022A1 (en) 2000-09-28
CN1356897A (zh) 2002-07-03
US6365631B1 (en) 2002-04-02

Similar Documents

Publication Publication Date Title
IL177626A0 (en) Pharmaceutical compositions for treating sleep apnoea
DE60039508D1 (de) Methoden zur behandlung der essstörungen
CA2296604A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
NO991425D0 (no) Medisinsk behandling
WO2000056315A8 (en) Treatment of pain
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
MXPA01009468A (es) Tratamiento de hipertension pulmonar.
SE0203778D0 (sv) A new oral immediated release dosage form
MXPA01009469A (es) Tratamiento para disminuir la adhesividad de las plaquetas.
BG105999A (en) Treatment of osteoarthritis
BG106000A (en) Treatment of hiatial hernia
WO2004026930A3 (en) The method for reducing inflammation using sti-571 or its salt
ATE228126T1 (de) 2- 4-(4-(4,5-dichlor-2-methylimidazol-1- yl)butyl)piperazin-1-yl -5-fluorpyrimidin, seine herstellung und therapeutische verwendung
MXPA01009462A (es) Tratamiento de calculos biliares.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application